Truist Securities Maintains Buy on Inspire Medical Systems, Lowers Price Target to $120

Benzinga · 3d ago
Truist Securities analyst Richard Newitter maintains Inspire Medical Systems (NYSE:INSP) with a Buy and lowers the price target from $165 to $120.